Contraceptive Devices for Women: Implants, Intrauterine Devices and Other Products

作者: Julie Craik , Sam Rowlands

DOI: 10.1007/978-3-319-12406-3_8

关键词: DiscontinuationContraceptive DevicesObstetricsEctopic pregnancyIntrauterine devicePerforation (oil well)Unintended pregnancyPelvic inflammatory diseaseMedicineMenstrual bleeding

摘要: This chapter focuses on progestogen-only implants and intrauterine devices. These methods have a high effectiveness with pregnancies being rare, however devices can be expelled. The inherent safety of both types device is good. Implants hormone-releasing produce hormonal side effects but also non-contraceptive benefits. levonorgesetrel system widely used in the treatment heavy menstrual bleeding. Contraceptive often cause changes bleeding which may result discontinuation method. There are some risks associated insertion removal scope for their reduction. Perforation uterus difficult to prevent usually relatively straightforward manage. Return fertility after all contraceptive rapid.

参考文章(213)
W J Hueston, K T Locke, Norplant neuropathy: peripheral neurologic symptoms associated with subdermal contraceptive implants. Journal of Family Practice. ,vol. 40, pp. 184- 186 ,(1995)
Jirawat Ponpuckdee, Surasak Taneepanichskul, The effects of implanon in the symptomatic treatment of endometriosis. Journal of the Medical Association of Thailand Chotmaihet thangphaet. ,(2005)
K L Doil, J Zerner, J Drewry, D A Leeber, Intrauterine contraceptive device failures in renal transplant patients. Journal of Reproductive Medicine. ,vol. 26, pp. 99- 102 ,(1981)
Erdoǧan Ertungealp, Contraception for women aged over 40 years CIC Edizioni internazionali. ,(2011)
Kerstin Andersson, Elsa Ryde-Blomqvist, Kerstin Lindell, Viveca Odlind, Ian Milsom, Perforations with intrauterine devices. Report from a Swedish survey. Contraception. ,vol. 57, pp. 251- 255 ,(1998) , 10.1016/S0010-7824(98)00029-8
Li Luo, Bing Luo, Ying Zheng, Heng Zhang, Jing Li, Neil Sidell, Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. Cochrane Database of Systematic Reviews. ,vol. 6, ,(2013) , 10.1002/14651858.CD009458.PUB2
Peter Schnabel, Gabriele S. Merki-Feld, Alice Malvy, Ingrid Duijkers, Ellen Mommers, Michiel W. van den Heuvel, Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study. Clinical Drug Investigation. ,vol. 32, pp. 413- 422 ,(2012) , 10.2165/11631930-000000000-00000